Actinium Pharmaceuticals, Inc.
ATNM· NYSE
ATNMActinium Pharmaceuticals, Inc.
Filed Mar 16, 2015 · 10-K · 75 days after period end · 0001213900-15-001800
derived · Computed from the longer spans the company filed.
| Metric | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011 |
|---|---|---|---|---|
| Revenue | — | — | — | $0.00 |
| Net Income | -$5.43M | -$5.88M | -$2.88M | -$4.01K |
| EPS Diluted | — | — | — |
Actinium Pharmaceuticals, Inc. · CIK 1388320 · Engraved from SEC EDGAR
| -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2014 · filed Mar 16, 2015 · 75 d after period end
